Veeva Systems Inc. (VEEV)
Automate Your Wheel Strategy on VEEV
With Tiblio's Option Bot, you can configure your own wheel strategy including VEEV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol VEEV
- Rev/Share 16.9136
- Book/Share 35.9156
- PB 7.7693
- Debt/Equity 0.013
- CurrentRatio 4.5114
- ROIC 0.0902
- MktCap 45470684160.0
- FreeCF/Share 6.7125
- PFCF 41.7143
- PE 63.4521
- Debt/Assets 0.0103
- DivYield 0
- ROE 0.1334
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Reiterated | VEEV | Needham | -- | Buy | $270 | $300 | May 29, 2025 |
| Downgrade | VEEV | Goldman | Buy | Sell | $261 | $200 | Jan. 23, 2025 |
| Initiation | VEEV | Stephens | -- | Overweight | -- | $280 | Dec. 20, 2024 |
| Initiation | VEEV | Mizuho | -- | Outperform | -- | $275 | Dec. 4, 2024 |
| Initiation | VEEV | Exane BNP Paribas | -- | Outperform | -- | $286 | Oct. 8, 2024 |
| Reiterated | VEEV | Citigroup | -- | Buy | $256 | $273 | Aug. 27, 2024 |
News
Veeva to Present at Upcoming Investor Conferences
Published: May 30, 2025 by: PRNewsWire
Sentiment: Neutral
PLEASANTON, Calif. , May 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conferences: Baird 2025 Global Consumer, Technology & Services Conference, New York, NY.
Read More
Veeva Systems Analysts Boost Their Forecasts After Better-Than-Expected Earnings
Published: May 29, 2025 by: Benzinga
Sentiment: Positive
Veeva Systems Inc. VEEV posted better-than-expected earnings for the first quarter and raised the outlook on Wednesday.
Read More
VEEV Stock Up as Q1 Earnings & Revenues Beat Estimates, Margin Rise
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva Systems' fiscal first-quarter results reflect impressive performance by the Subscription services segment, along with the expansion of gross and operating margins.
Read More
Veeva Stock Spikes 22% After Earnings Beat. What Analysts Are Saying.
Published: May 29, 2025 by: Barrons
Sentiment: Positive
The cloud-solutions company beats first-quarter earnings forecasts and issues better-than-expected fiscal-year guidance.
Read More
Reasons to Retain Veeva Systems Stock in Your Portfolio for Now
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
VEEV's robust product portfolio and a slew of strategic deals raise optimism about the stock.
Read More
2 AI-Driven Tech Stocks to Buy Before they Surge in June
Published: May 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Diving into some best-in-class, beaten-down tech stocks to buy before everyone else on Wall Street starts searching for deals again.
Read More
Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a Bet
Published: May 26, 2025 by: Zacks Investment Research
Sentiment: Negative
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
Veeva (VEEV) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Published: May 23, 2025 by: Zacks Investment Research
Sentiment: Neutral
Evaluate the expected performance of Veeva (VEEV) for the quarter ended April 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Read More
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It
Published: May 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know
Published: May 20, 2025 by: Zacks Investment Research
Sentiment: Negative
Veeva Systems (VEEV) closed the most recent trading day at $240.78, moving +0.48% from the previous trading session.
Read More
Saudi Arabia Pharmaceutical Quality Management Software Market Forecast and Opportunities, 2030F Featuring MasterControl, AmpleLogic, Pilgrim, Sparta Systems, Dassault, Veeva Systems, and Ideagen
Published: May 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
The Saudi Arabia Pharmaceutical Quality Management Software Market is projected to grow from USD 14.48 Million in 2024 to USD 26.92 Million by 2030, with a CAGR of 10.85%. This growth is driven by the expansion of the pharmaceutical industry and the increasing adoption of digital solutions like AI and cloud computing to enhance quality control. Compliance with strict regulatory standards and the push towards automation are also key factors in the market's development. Vision 2030 initiatives further boost the demand for innovative PQMS solutions to support the burgeoning pharmaceutical sector. The Saudi Arabia Pharmaceutical Quality Management Software Market is …
Read More
Life Sciences Leaders Advance Unified Engagement at Veeva Commercial Summit
Published: May 06, 2025 by: PRNewsWire
Sentiment: Neutral
AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly and Company, and more share strategies for more connected customer experiences across sales, marketing, and medical PLEASANTON, Calif. , May 6, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced its keynote speakers for the 2025 Veeva Commercial Summit, May 13-14 in Boston.
Read More
Veeva: Our 2025 Software Pick Just Keeps Winning
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Positive
I believe Veeva's robust product roadmap, including the introduction of Veeva AI, should deepen adoption and drive productivity across its Development and Commercial Cloud segments. Despite a projected revenue growth slowdown in FY26, Veeva's management remains confident in achieving its $6B revenue target by 2030. VEEV's strong financial discipline is evident, with non-GAAP operating margins expected to expand to 43% in FY26 despite a projected revenue slowdown.
Read More
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
3 Medical Info Systems Stocks to Ride the AI Wave in Trump Tariff Era
Published: April 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks Medical Info Systems industry stocks like VEEV, HIMS and BFLY are expected to gain from the Stargate Project and provide relief amid tariff tension.
Read More
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy?
Published: April 18, 2025 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
Flatiron Health Joins Veeva's Product Partner Program to Accelerate Oncology Clinical Research
Published: April 16, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Flatiron Health, a healthtech company transforming clinical research through solutions that integrate research into everyday care, today announced they will partner with Veeva Systems, a global leader in cloud software for the life sciences industry. As part of the partnership, Flatiron Health will join the Veeva Product Partner Program. This collaboration builds on the integration of Flatiron Clinical Pipe™ and Veeva EDC (Electronic Data Capture), enhancing value and.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: April 11, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last?
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva (VEEV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Read More
Why Is Veeva (VEEV) Down 6.2% Since Last Earnings Report?
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Negative
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock?
Read More
New Strong Buy Stocks for April 3rd
Published: April 03, 2025 by: Zacks Investment Research
Sentiment: Positive
NATL, BGC, NPSNY, ALX and VEEV have been added to the Zacks Rank #1 (Strong Buy) List on April 3, 2025.
Read More
Best Momentum Stocks to Buy for April 3rd
Published: April 03, 2025 by: Zacks Investment Research
Sentiment: Positive
VEEV, BNPQY and NECB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 3, 2025.
Read More
VEEV Stock Slips Despite New Research Site Clinical Trial System
Published: April 02, 2025 by: Zacks Investment Research
Sentiment: Neutral
Veeva introduces a Research Site Clinical Trial Management System to streamline trial operations, enhance collaboration, and accelerate clinical research efficiency.
Read More
Wall Street Analysts Think Veeva (VEEV) Is a Good Investment: Is It?
Published: April 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
5 Momentum Stocks to Buy for April Despite a Disappointing March
Published: April 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Five stocks have strong momentum for April. These are: APP, MRVL, DOCS, RDDT, VEEV.
Read More
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
Published: March 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Read More
VEEV Stock Gains Following Latest Availability of HCP Access Data
Published: March 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva Systems aims to provide immediate value for commercial operations and data analytics teams via CRM Pulse, which provides quarterly HCP access data.
Read More
Veeva Systems: Solid Q4 With Margin Expansion
Published: March 07, 2025 by: Seeking Alpha
Sentiment: Positive
I reiterate my “Strong Buy” rating on Veeva Systems Inc. with a one-year target price of $275 per share due to strong CRM migration and margin improvement. Veeva reported 14.3% revenue growth and 28.7% adjusted operating profit growth, driven by robust CRM adoption and billing growth. Management's guidance for FY26 includes $3.04-$3.055 billion in revenue, with anticipated 12% revenue growth despite high-interest rate challenges.
Read More
Why Veeva Systems Stock Is Surging Today
Published: March 06, 2025 by: The Motley Fool
Sentiment: Positive
Shares of Veeva Systems (VEEV 9.05%) are posting big gains in Thursday's trading despite broader sell-offs for the tech sector. The life-sciences software company's stock was up 10.2% as of 12:30 p.m.
Read More
VEEV Stock Up as Q4 Earnings & Revenues Beat Estimates, Margin Rise
Published: March 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva Systems' fiscal fourth-quarter results reflect impressive performance by the Subscription services segment, along with the expansion of gross and operating margins.
Read More
About Veeva Systems Inc. (VEEV)
- IPO Date 2013-10-16
- Website https://www.veeva.com
- Industry Medical - Healthcare Information Services
- CEO Mr. Peter P. Gassner
- Employees 7291